WallStreetZenWallStreetZen

NYSE: BIO
Bio Rad Laboratories Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bio Rad Laboratories earnings were $319.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest BIO earnings report on Jun 30, 2025 announced Q2 2025 earnings of $317.8M, up 396.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BIO reported annual earnings of -$1.8B, with 189.4% growth. The next BIO earnings date is Oct 23, 2025.

BIO past earnings growth

How has BIO's earnings growth performed historically?

Company
N/A
Industry
82.81%
Market
29.88%
BIO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BIO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BIO earnings history

Current Revenue
$2.6B
Current Earnings
$319.2M
Current Profit Margin
12.5%
BIO's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BIO Return on Equity

Current Company
4.6%
Current Industry
15.2%
Current Market
31.2%
BIO's Return on Equity (4.6%)... subscribe to Premium to read more.
High Return on Equity Performance

BIO undefined

Current Company
3.2%
Current Industry
8.9%
BIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BIO announces earnings.

BIO undefined

Current Company
5.16%
Current Industry
10.6%
BIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIO vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BIO$499.06M$319.17M-28.93%$11.86
MASI-$366.00M-$459.20MN/A-$8.60
GMED$643.01M$356.65M+23.92%$2.63
ALGN$815.17M$437.61M-22.78%$5.94
IRTC-$52.28M-$92.43MN/A-$2.93
View Top Medical Device Stocks

BIO earnings dates

Next earnings date
Oct 23, 2025

Bio Rad Laboratories Earnings Reports & History FAQ

What were Bio Rad Laboratories's earnings last quarter?

On BIO's earnings call on Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q2 2025 earnings per share (EPS) of $11.67, up 115.3% year over year. Total BIO earnings for the quarter were $317.80 million. In the same quarter last year, Bio Rad Laboratories's earnings per share (EPS) was -$76.26.

If you're new to stock investing, here's how to buy Bio Rad Laboratories stock.

When does Bio Rad Laboratories report earnings?

The next BIO earnings date is Invalid Date. Add BIO to your watchlist to be reminded of Bio Rad Laboratories's next earnings date.

Is Bio Rad Laboratories profitable or losing money?

As of the last Bio Rad Laboratories earnings report, Bio Rad Laboratories is currently profitable. Bio Rad Laboratories's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $319.17 million, a 124.08% decrease year over year.

What was BIO's earnings growth in the past year?

As of Bio Rad Laboratories's earnings date in Invalid Date, Bio Rad Laboratories's earnings has grown year over year. BIO earnings in the past year totalled $319.17 million.

What are Bio Rad Laboratories's earnings expectations?

The current EPS estimate for Bio Rad Laboratories's earnings report in Invalid Date is $1.97.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.